Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance.

Literature DB >> 10071007

Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance.

R Temple¹.

Abstract

Mesh：

Year: 1999 PMID： 10071007 DOI： 10.1001/jama.281.9.841

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?

Authors: W K Kraft; S A Waldman
Journal: Drug Saf Date: 2001 Impact factor: 5.606

2. Development safety update reports and proposals for effective and efficient risk communication.

Authors: Hisashi Urushihara; Koji Kawakami
Journal: Drug Saf Date: 2010-05-01 Impact factor: 5.606

3. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.

Authors: Mark H Kuniholm; Andrea Kovacs; Xiaojiang Gao; Xiaonan Xue; Darlene Marti; Chloe L Thio; Marion G Peters; Norah A Terrault; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Tiffany G Harris; Mary A Young; Howard D Strickler; Mary Carrington
Journal: Hepatology Date: 2010-05 Impact factor: 17.425

4. Late adverse events after drug-eluting stent implantation.

Authors: David F Kong; Eric L Eisenstein; Robert Harrington
Journal: Curr Cardiol Rep Date: 2008-07 Impact factor: 2.931

5. The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis system.

Authors: Christian G Reich; Patrick B Ryan; Marc A Suchard
Journal: Drug Saf Date: 2013-10 Impact factor: 5.606

6. Evaluating performance of risk identification methods through a large-scale simulation of observational data.

Authors: Patrick B Ryan; Martijn J Schuemie
Journal: Drug Saf Date: 2013-10 Impact factor: 5.606

Review 7. The dangers of hazards.

Authors: Colin Berry
Journal: Toxicol Res (Camb) Date: 2016-01-12 Impact factor: 3.524